A Delayed Adverse Reaction: Hydralazine-Induced Lupus After Years of Use
Saurav Paudel, Ayushma Acharya, Sanjiv Poudel, Swarup Sharma Rijal

TL;DR
A 61-year-old woman developed lupus-like symptoms after years of hydralazine use, which resolved after stopping the drug and starting treatment.
Contribution
This case highlights hydralazine-induced lupus can develop years after drug exposure and be successfully treated.
Findings
Symptoms resolved after discontinuing hydralazine and starting corticosteroids and methotrexate.
Anti-nuclear antibody and anti-histone antibodies confirmed drug-induced lupus.
A false-positive Lyme antibody test complicated the diagnosis.
Abstract
Drug-induced lupus (DIL) is a rare autoimmune condition triggered by certain medications, most commonly hydralazine and procainamide. DIL can manifest after a few weeks or even after several years of drug exposure. We present a case of a 61-year-old female with hypertension and type 2 diabetes mellitus who developed progressive polyarthritis, myalgia, and fatigue that developed over a year after three years of hydralazine use. Laboratory findings revealed anemia, leukopenia, elevated inflammatory markers, an anti-nuclear antibody (ANA) titer of 1:2560, and anti-histone antibodies of 4.9 units. A false-positive immunoglobulin M (IgM) Lyme antibody complicated the diagnostic workup. Discontinuation of hydralazine and initiation of corticosteroid and methotrexate resulted in resolution after six weeks, confirming the diagnosis of hydralazine-induced lupus.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSystemic Lupus Erythematosus Research
